Mark B. Roth

Mark Roth has served as a member of the Board of Directors since the company’s founding in 2014. Dr. Roth is a member of the Division of Basic Sciences at the Fred Hutchinson Cancer Research Center, a position he has held since 1989, and an affiliate professor in the Department of Biochemistry at the University of Washington. He is the founder of Ikaria, Inc., which was formed in 2005. Ikaria was acquired by Mallinckrodt Plc in 2015. Dr. Roth’s pioneering research has included molecular mechanisms of gene regulation, animal physiology, and medical diagnostics. Following his discovery of a class of molecules known as SR proteins, Dr. Roth developed a diagnostic assay for systemic lupus erythematosus, which received FDA approval. He is most noted for his experimental work on new clinical procedures for the temporary reduction of metabolism using endogenous essential ions. In 2007, Dr. Roth was named a MacArthur fellow by the John D. and Catherine T. MacArthur Foundation. In 2007 he also received a Significant Technical Achievement Award from the Defense Advanced Research Projects Agency (DARPA) and in 2006 was an invited speaker at the White House Fellows National Meeting, Washington, D.C. Dr. Roth received a B.Sc. from the University of Oregon and a Ph.D. from the University of Colorado at Boulder.